Загрузка...
Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients
BACKGROUND: To evaluate resource use and health costs due to the combination of metformin and dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with diabetes and renal impairment in routine clinical practice. METHODS: An observational, retrospective study was performed. Patients aged ≥30 years t...
Сохранить в:
| Опубликовано в: : | Diabetes Metab J |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Diabetes Association
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4342540/ https://ncbi.nlm.nih.gov/pubmed/25729716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2015.39.1.74 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|